Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.
2.

WNT signaling in ovarian follicle biology and tumorigenesis.

Boyer A, Goff AK, Boerboom D.

Trends Endocrinol Metab. 2010 Jan;21(1):25-32. doi: 10.1016/j.tem.2009.08.005. Epub 2009 Oct 28. Review.

PMID:
19875303
3.

Wnt signaling: physiology and pathology.

Prunier C, Hocevar BA, Howe PH.

Growth Factors. 2004 Sep;22(3):141-50. Review.

PMID:
15518237
4.

Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.

Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, Inestrosa NC.

Brain Res Brain Res Rev. 2004 Dec;47(1-3):275-89. Review.

PMID:
15572177
5.

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

Takahashi-Yanaga F, Kahn M.

Clin Cancer Res. 2010 Jun 15;16(12):3153-62. doi: 10.1158/1078-0432.CCR-09-2943. Epub 2010 Jun 8. Review.

6.

Impact of WNT signaling on tissue lineage differentiation in the early mouse embryo.

Tanaka SS, Kojima Y, Yamaguchi YL, Nishinakamura R, Tam PP.

Dev Growth Differ. 2011 Sep;53(7):843-56. doi: 10.1111/j.1440-169X.2011.01292.x. Epub 2011 Jul 15. Review.

PMID:
21762130
7.

Wnt signaling in the intestinal epithelium: from endoderm to cancer.

Gregorieff A, Clevers H.

Genes Dev. 2005 Apr 15;19(8):877-90. Review.

9.

The Wnt signaling pathway in retinal degenerations.

Hackam AS.

IUBMB Life. 2005 Jun;57(6):381-8. Review.

10.

Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.

Kim Y, Sills RC, Houle CD.

Toxicol Pathol. 2005;33(1):175-80. Review.

PMID:
15805069
11.

Wnt signalling and prostate cancer.

Yardy GW, Brewster SF.

Prostate Cancer Prostatic Dis. 2005;8(2):119-26. Review.

PMID:
15809669
12.
13.

The Wnt signaling pathway in development and disease.

Logan CY, Nusse R.

Annu Rev Cell Dev Biol. 2004;20:781-810. Review.

PMID:
15473860
14.

Molecular pathogenesis of granulosa cell tumours.

Fuller PJ, Chu S, Fikret S, Burger HG.

Mol Cell Endocrinol. 2002 May 31;191(1):89-96. Review.

PMID:
12044922
15.

Wnt signaling in disease and in development.

Nusse R.

Cell Res. 2005 Jan;15(1):28-32. Review.

16.

The Wnt/β-catenin pathway in ovarian cancer: a review.

Arend RC, Londoño-Joshi AI, Straughn JM Jr, Buchsbaum DJ.

Gynecol Oncol. 2013 Dec;131(3):772-9. doi: 10.1016/j.ygyno.2013.09.034. Epub 2013 Oct 11. Review.

PMID:
24125749
17.

Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours.

Fuller PJ, Chu S.

Trends Endocrinol Metab. 2004 Apr;15(3):122-8. Review.

PMID:
15046741
18.

Identification of Wnt family inhibitors: a pituitary tumor directed whole genome approach.

Elston MS, Clifton-Bligh RJ.

Mol Cell Endocrinol. 2010 Sep 15;326(1-2):48-54. doi: 10.1016/j.mce.2010.02.039. Epub 2010 Mar 6. Review.

PMID:
20211224
19.

[Antagonists of Wnt pathway].

Kinoshita Y, Fukumoto S.

Clin Calcium. 2013 Jun;23(6):817-23. doi: CliCa1306817823. Review. Japanese.

PMID:
23719493
20.

[Mechanisms controlling the fate of hematopoietic stem cells].

Ema H.

Tanpakushitsu Kakusan Koso. 2004 May;49(6):734-40. Review. Japanese. No abstract available.

PMID:
15160882

Supplemental Content

Support Center